Maotian Zhou

Affiliations: 
Biochemistry Emory University, Atlanta, GA 
Google:
"Maotian Zhou"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ma Y, Dammer EB, Felsky D, et al. (2021) Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. Nature Communications. 12: 7035
Guo Q, Dammer EB, Zhou M, et al. (2021) Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease. Frontiers in Molecular Neuroscience. 14: 623659
Xu MM, Zhou MT, Li SW, et al. (2021) Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach. Journal of Neuroscience Research
Higginbotham L, Ping L, Dammer EB, et al. (2020) Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Science Advances. 6
Zhou M, Haque RU, Dammer EB, et al. (2020) Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease. Clinical Proteomics. 17: 19
Johnson ECB, Dammer EB, Duong DM, et al. (2020) Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nature Medicine
Higginbotham LA, Ping L, Dammer EB, et al. (2020) Proteomics identifies CSF biomarker panels reflective of pathological networks in the Alzheimer's disease brain Alzheimer's & Dementia. 16
Johnson EC, Dammer EB, Duong D, et al. (2020) A consensus proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation Alzheimer's & Dementia. 16
Zhou M, Duong DM, Johnson ECB, et al. (2019) Mass spectrometry-based quantification of Tau in human cerebrospinal fluid using a complementary tryptic peptide standard. Journal of Proteome Research
Ping L, Higginbotham LA, Dammer EB, et al. (2019) INTEGRATIVE PROTEOMICS LINKS CEREBROSPINAL FLUID BIOMARKERS TO PATHOLOGICAL NETWORKS IN THE ALZHEIMER’S DISEASE BRAIN Alzheimer's & Dementia. 15: P191
See more...